Explore the Potential with AI-Driven Innovation
The specialised, focused library is developed on demand with the most recent virtual screening and parameter assessment technology, guided by the Receptor.AI drug discovery platform. This approach exceeds the capabilities of traditional methods and offers compounds with higher activity, selectivity, and safety.
From a virtual chemical space containing more than 60 billion molecules, we precisely choose certain compounds. Our collaborator, Reaxense, aids in their synthesis and provision.
The library includes a list of the most effective modulators, each annotated with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Furthermore, each compound is shown with its optimal docking poses, affinity scores, and activity scores, offering a detailed summary.
We employ our advanced, specialised process to create targeted libraries for enzymes.
Fig. 1. The sreening workflow of Receptor.AI
This approach involves comprehensive molecular simulations of the catalytic and allosteric binding pockets and ensemble virtual screening that accounts for their conformational flexibility. In the case of designing modulators, the structural adjustments caused by reaction intermediates are considered to improve activity and selectivity.
Several key aspects differentiate our library:
partner
Reaxense
upacc
P02776
UPID:
PLF4_HUMAN
Alternative names:
C-X-C motif chemokine 4; Iroplact; Oncostatin-A
Alternative UPACC:
P02776; Q53X61; Q9UC64; Q9UC65
Background:
Platelet factor 4, also known as C-X-C motif chemokine 4, Iroplact, and Oncostatin-A, plays a crucial role in the body's response to injury and inflammation. It is released during platelet aggregation and has a unique ability to neutralize the anticoagulant effects of heparin. This protein is not only a chemotactic agent for neutrophils and monocytes but also a significant inhibitor of endothelial cell proliferation, with its shorter form being more potent.
Therapeutic significance:
Understanding the role of Platelet factor 4 could open doors to potential therapeutic strategies. Its involvement in modulating inflammation and coagulation processes highlights its potential as a target for developing treatments for inflammatory and coagulation disorders.